Marrone Bio Innovations I...

NASDAQ: MBII · Real-Time Price · USD
0.80
-0.20 (-20.00%)
At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-16.55M
Depreciation & Amortization
4.57M
Stock-Based Compensation
3.35M
Other Working Capital
3.66M
Other Non-Cash Items
-495K
Deferred Income Tax
n/a
Change in Working Capital
-830K
Operating Cash Flow
-9.96M
Capital Expenditures
-1.09M
Cash Acquisitions
n/a
Purchase of Investments
n/a
Sales Maturities Of Investments
n/a
Other Investing Acitivies
-750K
Investing Cash Flow
-1.84M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
15.59M
Financial Cash Flow
15.59M
Net Cash Flow
3.78M
Free Cash Flow
-11.05M